Lantheus Holdings, Inc. (LNTH)
USD 108.74
(2.66%)
USD 108.74
(2.66%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 616.94 Million USD | 10.55% |
| 2022 | 558.06 Million USD | 219.33% |
| 2021 | 174.76 Million USD | -19.98% |
| 2020 | 218.4 Million USD | 12.54% |
| 2019 | 194.07 Million USD | -27.17% |
| 2018 | 266.45 Million USD | -0.63% |
| 2017 | 268.14 Million USD | -3.58% |
| 2016 | 278.11 Million USD | -21.33% |
| 2015 | 353.5 Million USD | -13.2% |
| 2014 | 407.28 Million USD | 0.06% |
| 2013 | 407.03 Million USD | 2.06% |
| 2012 | 398.82 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 563.2 Million USD | -8.71% |
| 2024 Q2 | 620.27 Million USD | 10.13% |
| 2023 FY | 616.94 Million USD | 10.55% |
| 2023 Q3 | 615.69 Million USD | 4.2% |
| 2023 Q4 | 616.94 Million USD | 0.2% |
| 2023 Q1 | 558.95 Million USD | 0.16% |
| 2023 Q2 | 590.87 Million USD | 5.71% |
| 2022 Q4 | 558.06 Million USD | 205.32% |
| 2022 Q2 | 185.5 Million USD | 7.7% |
| 2022 Q1 | 172.24 Million USD | -1.44% |
| 2022 FY | 558.06 Million USD | 219.33% |
| 2022 Q3 | 182.78 Million USD | -1.47% |
| 2021 FY | 174.76 Million USD | -19.98% |
| 2021 Q1 | 181.72 Million USD | -16.79% |
| 2021 Q2 | 179.62 Million USD | -1.16% |
| 2021 Q3 | 177.09 Million USD | -1.41% |
| 2021 Q4 | 174.76 Million USD | -1.32% |
| 2020 FY | 218.4 Million USD | 12.54% |
| 2020 Q1 | 191.63 Million USD | -1.26% |
| 2020 Q3 | 222.8 Million USD | -1.91% |
| 2020 Q4 | 218.4 Million USD | -1.98% |
| 2020 Q2 | 227.15 Million USD | 18.54% |
| 2019 Q2 | 198.84 Million USD | -25.29% |
| 2019 Q4 | 194.07 Million USD | -1.26% |
| 2019 FY | 194.07 Million USD | -27.17% |
| 2019 Q1 | 266.14 Million USD | -0.12% |
| 2019 Q3 | 196.53 Million USD | -1.16% |
| 2018 Q4 | 266.45 Million USD | -0.16% |
| 2018 Q1 | 267.72 Million USD | -0.16% |
| 2018 FY | 266.45 Million USD | -0.63% |
| 2018 Q2 | 267.3 Million USD | -0.16% |
| 2018 Q3 | 266.88 Million USD | -0.16% |
| 2017 Q4 | 268.14 Million USD | -0.05% |
| 2017 FY | 268.14 Million USD | -3.58% |
| 2017 Q3 | 268.27 Million USD | -0.15% |
| 2017 Q2 | 268.67 Million USD | -0.15% |
| 2017 Q1 | 269.08 Million USD | -3.25% |
| 2016 Q4 | 278.11 Million USD | -6.75% |
| 2016 FY | 278.11 Million USD | -21.33% |
| 2016 Q1 | 352.99 Million USD | -0.14% |
| 2016 Q2 | 352.48 Million USD | -0.14% |
| 2016 Q3 | 298.23 Million USD | -15.39% |
| 2015 Q3 | 354.01 Million USD | -0.16% |
| 2015 Q4 | 353.5 Million USD | -0.14% |
| 2015 Q2 | 354.57 Million USD | -12.95% |
| 2015 Q1 | 407.34 Million USD | 0.02% |
| 2015 FY | 353.5 Million USD | -13.2% |
| 2014 Q4 | 407.28 Million USD | 0.01% |
| 2014 FY | 407.28 Million USD | 0.06% |
| 2014 Q1 | 407.09 Million USD | 0.01% |
| 2014 Q2 | 412.65 Million USD | 1.37% |
| 2014 Q3 | 407.22 Million USD | -1.32% |
| 2013 FY | 407.03 Million USD | 2.06% |
| 2013 Q1 | 399.75 Million USD | 0.0% |
| 2013 Q3 | 407.1 Million USD | -0.08% |
| 2013 Q2 | 407.42 Million USD | 1.92% |
| 2013 Q4 | 407.03 Million USD | -0.02% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | 398.82 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 540.94 Million USD | -14.049% |
| Theratechnologies Inc. | 58.96 Million USD | -946.239% |
| Safety Shot Inc | 1.54 Million USD | -39729.332% |
| Cosmos Health Inc. | 12.42 Million USD | -4865.779% |
| Cronos Group Inc. | 2.53 Million USD | -24189.805% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 13.779% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | -1598.5% |
| Organogenesis Holdings Inc. | 119.35 Million USD | -416.917% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -11153.095% |
| ProPhase Labs, Inc. | 21.38 Million USD | -2785.622% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -101371.382% |
| Dynavax Technologies Corporation | 256.91 Million USD | -140.137% |
| Radius Health, Inc. | 365.31 Million USD | -68.881% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -23203.361% |
| Alvotech | 1.07 Billion USD | 42.635% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -93702.845% |
| Alpha Teknova, Inc. | 30.45 Million USD | -1925.563% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -3542.378% |
| SCYNEXIS, Inc. | 15.08 Million USD | -3991.154% |
| Harrow Health, Inc. | 190.5 Million USD | -223.853% |
| Biofrontera Inc. | 5.39 Million USD | -11327.042% |
| DURECT Corporation | 20.74 Million USD | -2873.807% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -1385.65% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | -95.652% |
| OptiNose, Inc. | 131.74 Million USD | -368.274% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -52495.298% |
| Aquestive Therapeutics, Inc. | 98.82 Million USD | -524.3% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -3247.785% |
| SIGA Technologies, Inc. | 1.46 Million USD | -42040.861% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | -373.263% |
| Shineco, Inc. | 29.65 Million USD | -1980.31% |
| Phibro Animal Health Corporation | 525.45 Million USD | -17.411% |
| Procaps Group S.A. | 285.93 Million USD | -115.764% |
| TherapeuticsMD, Inc. | 8 Million USD | -7607.008% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -1031461.523% |
| Viatris Inc. | 18.12 Billion USD | 96.596% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -93702.845% |
| Rockwell Medical, Inc. | 13.43 Million USD | -4490.714% |
| Incannex Healthcare Limited | 373 Thousand USD | -165301.072% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -3977.903% |
| Tilray Brands, Inc. | 387.31 Million USD | -59.287% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 8.503% |
| PetIQ, Inc. | 468.3 Million USD | -31.741% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | -44.012% |
| Journey Medical Corporation | 17.73 Million USD | -3379.673% |
| Alimera Sciences, Inc. | 67.39 Million USD | -815.364% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -7354.108% |
| Assertio Holdings, Inc. | 40.91 Million USD | -1407.983% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -56620.548% |
| Embecta Corp. | 1.63 Billion USD | 62.347% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -59617.069% |
| Procaps Group, S.A. | 285.93 Million USD | -115.764% |
| PainReform Ltd. | 86 Thousand USD | -717279.07% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | -1643.573% |
| Hempacco Co., Inc. | 13.72 Million USD | -4395.215% |
| Talphera, Inc. | - USD | -Infinity% |
| Pacira BioSciences, Inc. | 586.04 Million USD | -5.273% |
| Alvotech | 1.07 Billion USD | 42.635% |
| Kamada Ltd. | 8.74 Million USD | -6951.628% |
| Indivior PLC | 281.6 Million USD | -119.085% |
| Currenc Group, Inc. | 31.94 Million USD | -1831.358% |
| Evoke Pharma, Inc. | 5 Million USD | -12238.92% |
| Flora Growth Corp. | 3.67 Million USD | -16701.362% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -59617.069% |
| Evolus, Inc. | 126.54 Million USD | -387.527% |
| HUTCHMED (China) Limited | 86.13 Million USD | -616.288% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 1.074% |
| Akanda Corp. | 3.99 Million USD | -15328.313% |